These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6531020)

  • 1. Psoralens: a search for more effective derivatives for photochemotherapeutic regimens.
    Willis I; Menter JM
    Natl Cancer Inst Monogr; 1984 Dec; 66():143-7. PubMed ID: 6531020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels.
    Kornhauser A; Wamer WG; Giles AL
    Natl Cancer Inst Monogr; 1984 Dec; 66():97-101. PubMed ID: 6531046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical evaluation of new antiproliferative agents for the photochemotherapy of psoriasis: angelicin derivatives.
    Bordin F; Baccichetti F; Carlassare F; Peron M; Dall'Acqua F; Vedaldi D; Guiotto A; Rodighiero P; Pathak MA
    Farmaco Sci; 1981 Jul; 36(7):506-18. PubMed ID: 7274437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic effects of monofunctional and bifunctional furocoumarins.
    Mullen MP; Pathak MA; West JD; Harrist TJ; Dall'Acqua F
    Natl Cancer Inst Monogr; 1984 Dec; 66():205-10. PubMed ID: 6531030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azapsoralens: new potential photochemotherapeutic agents for psoriasis.
    Vedaldi D; Caffieri S; Miolo G; Dall'Acqua F; Baccichetti F; Guiotto A; Benetollo F; Bombieri G; Recchia G; Cristofolini M
    Farmaco; 1991 Dec; 46(12):1407-33. PubMed ID: 1821628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemotherapy: a new promising chemical derivative.
    Willis I
    Arch Dermatol Res; 1982; 272(3-4):251-6. PubMed ID: 7165333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-Methylangelicin derivatives: a new group of highly photosensitizing monofunctional furocoumarins.
    Baccichetti F; Bordin F; Carlassare F; Rodighiero P; Guiotto A; Peron M; Capozzi A; Dall'Acqua F
    Farmaco Sci; 1981 Jul; 36(7):585-97. PubMed ID: 7023974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of psoralens after oral administration: considerations and conclusions.
    Brickl R; Schmid J; Koss FW
    Natl Cancer Inst Monogr; 1984 Dec; 66():63-7. PubMed ID: 6531040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralen pharmacology: studies on metabolism and enzyme induction.
    Bickers DR; Pathak MA
    Natl Cancer Inst Monogr; 1984 Dec; 66():77-84. PubMed ID: 6531043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoreactive water-soluble derivatives of psoralen.
    Marciani Magno S; Antonello C; Baccichetti F; Gia O; Rodighiero G; Pathak MA
    Farmaco Sci; 1981 Jan; 36(1):13-22. PubMed ID: 7202706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
    Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative tests for psoralens in the blood: methods and uses in monitoring psoralen and longwave radiation therapy.
    Carter DM; Goldstein DP
    Natl Cancer Inst Monogr; 1984 Dec; 66():69-72. PubMed ID: 6531041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photophysical and photobiological properties of 3-carbethoxypsoralen.
    Joshi PC; Pathak MA
    Indian J Biochem Biophys; 1995 Apr; 32(2):63-73. PubMed ID: 7642202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.
    Hansen JB; Bjerring P; Buchardt O; Ebbesen P; Kanstrup A; Karup G; Knudsen PH; Nielsen PE; Nordén B; Ygge B
    J Med Chem; 1985 Aug; 28(8):1001-10. PubMed ID: 4020822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental bases and primary trials of photochemotherapy of psoriasis by a non-cancerigenic monofunctional furocoumarin, 3-carbethoxypsoralen].
    Dubertret L; Averbeck D; Bisagni E
    C R Seances Acad Sci D; 1979 Mar; 288(11):975-7. PubMed ID: 111837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of phototoxic substances on simple biological systems. I. Standardizing the method with furocoumarins].
    Schlacke KH; Geier J; Dittrich F; Ippen H
    Z Hautkr; 1990 Aug; 65(8):717-24. PubMed ID: 2126651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the relationship between photosensitizing and therapeutic activity of 4,5',8-trimethylpsoralen, and its major metabolite 4,8-dimethyl, 5'-carboxypsoralen.
    Pathak MA; Marciani MS; Guiotto A; Rodighiero G
    J Invest Dermatol; 1983 Dec; 81(6):533-9. PubMed ID: 6644095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.